SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-040041
Filing Date
2023-02-15
Accepted
2023-02-15 13:19:28
Documents
2
Group Members
ERIC D. ANDERSENWESTERN STANDARD PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d449015dsc13ga.htm SC 13G/A 80604
2 EX-99.A d449015dex99a.htm EX-99.A 5529
  Complete submission text file 0001193125-23-040041.txt   88083
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Subject) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90404 | Film No.: 23634747
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90036
Business Address 5900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90036 3107465639
Western Standard LLC (Filed by) CIK: 0001517666 (see all company filings)

IRS No.: 133604093 | State of Incorp.: CA
Type: SC 13G/A